Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Frankel

Showing results (221-230 of 259) with videos related to

Pageof 26
Sort By:
Cancer Research|March 1, 1987
Antitumor activity of an immunotoxin in a nude mouse model of human ovarian cancerD J FitzGerald, M J Bjorn, R J Ferris, et al.
Cancer Research|June 1, 1989
Distribution and physical properties of BCA200, a Mr 200,000 glycoprotein selectively associated with human breast cancerD B Ring, J A Kassel, S T Hsieh-Ma, et al.
Seminars in Pediatric Surgery|August 1, 1996
Molecular biology and the pediatric surgeon: definitions and basic methodologyE P Tagge, D U Tagge, J C Chandler, et al.
Molecular Cancer Therapeutics|May 17, 2008
Cytotoxicity of the matrix metalloproteinase-activated anthrax lethal toxin is dependent on gelatinase expression and B-RAF status in human melanoma cellsRandall W Alfano, Stephen H Leppla, Shihui Liu, et al.
Protein Expression and Purification|December 28, 2007
GMP production and characterization of the bivalent anti-human T cell immunotoxin, A-dmDT390-bisFv(UCHT1) for phase I/II clinical trialsJung Hee Woo, Jen-Sing Liu, Soo Hyun Kang, et al.
Blood|December 3, 1998
Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor is toxic to blasts from patients with juvenile myelomonocytic leukemia and chronic myelomonocytic leukemiaA E Frankel, M Lilly, R Kreitman, et al.
Blood|July 10, 1998
Malignant progenitors from patients with acute myelogenous leukemia are sensitive to a diphtheria toxin-granulocyte-macrophage colony-stimulating factor fusion proteinD E Hogge, C L Willman, R J Kreitman, et al.
Cancer Immunology, Immunotherapy : CII|February 8, 2008
Preclinical studies in rats and squirrel monkeys for safety evaluation of the bivalent anti-human T cell immunotoxin, A-dmDT390-bisFv(UCHT1)Jung Hee Woo, Sarah H Bour, Tony Dang, et al.
Journal of Cancer Research and Therapeutics|September 15, 2020
Epidermal growth factor receptor-activating mutation(E746_T751>VP) in pancreatic ductal adenocarcinoma responds to erlotinib, followed by epidermal growth factor receptor resistance-mediating mutation (A647T): A case report and literature reviewGirijesh Kumar Patel, Josiah B Perry, Osama Abdul-Rahim, et al.
Oncotarget|July 27, 2018
Tumor endothelial marker 8 promotes cancer progression and metastasisAnette M Høye, Sofie D Tolstrup, Edward R Horton, et al.
Pageof 26

Showing results (221-230 of 259) with videos related to

Sort By:
Pageof 26
Cancer Research|March 1, 1987
Antitumor activity of an immunotoxin in a nude mouse model of human ovarian cancerD J FitzGerald, M J Bjorn, R J Ferris, et al.
Cancer Research|June 1, 1989
Distribution and physical properties of BCA200, a Mr 200,000 glycoprotein selectively associated with human breast cancerD B Ring, J A Kassel, S T Hsieh-Ma, et al.
Seminars in Pediatric Surgery|August 1, 1996
Molecular biology and the pediatric surgeon: definitions and basic methodologyE P Tagge, D U Tagge, J C Chandler, et al.
Molecular Cancer Therapeutics|May 17, 2008
Cytotoxicity of the matrix metalloproteinase-activated anthrax lethal toxin is dependent on gelatinase expression and B-RAF status in human melanoma cellsRandall W Alfano, Stephen H Leppla, Shihui Liu, et al.
Protein Expression and Purification|December 28, 2007
GMP production and characterization of the bivalent anti-human T cell immunotoxin, A-dmDT390-bisFv(UCHT1) for phase I/II clinical trialsJung Hee Woo, Jen-Sing Liu, Soo Hyun Kang, et al.
Blood|December 3, 1998
Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor is toxic to blasts from patients with juvenile myelomonocytic leukemia and chronic myelomonocytic leukemiaA E Frankel, M Lilly, R Kreitman, et al.
Blood|July 10, 1998
Malignant progenitors from patients with acute myelogenous leukemia are sensitive to a diphtheria toxin-granulocyte-macrophage colony-stimulating factor fusion proteinD E Hogge, C L Willman, R J Kreitman, et al.
Cancer Immunology, Immunotherapy : CII|February 8, 2008
Preclinical studies in rats and squirrel monkeys for safety evaluation of the bivalent anti-human T cell immunotoxin, A-dmDT390-bisFv(UCHT1)Jung Hee Woo, Sarah H Bour, Tony Dang, et al.
Journal of Cancer Research and Therapeutics|September 15, 2020
Epidermal growth factor receptor-activating mutation(E746_T751>VP) in pancreatic ductal adenocarcinoma responds to erlotinib, followed by epidermal growth factor receptor resistance-mediating mutation (A647T): A case report and literature reviewGirijesh Kumar Patel, Josiah B Perry, Osama Abdul-Rahim, et al.
Oncotarget|July 27, 2018
Tumor endothelial marker 8 promotes cancer progression and metastasisAnette M Høye, Sofie D Tolstrup, Edward R Horton, et al.
Pageof 26